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ABSTRACT 
 
 Introductions: Postoperative sore throat (POST) is a commonly seen 
adverse event after general anesthesia with endotracheal intubation. 
Dexamethasone, a potent corticosteroid with anti-inflammatory action is 
the most popular steroid studied in this regard with positive results. 
 
Methods: This randomized, prospective, double-blinded, placebo-
controlled study was conducted on one hundred and ten adult patients 
of either sex, American Society of Anesthesiologists physical status I & II, 
undergoing elective surgeries requiring endotracheal tube intubation. 
After obtaining written informed consent, they were randomly divided 
into Control (A, n=55) and Dexamethasone (B, n=55) groups and received 
either an injection of Dexamethasone (Group B) 8 mg intravenously or an 
equivalent volume of Normal Saline (Group A) just before entering the 
operating theatre. All the patients received a similar anesthesia with 
endotracheal tube intubation and at the end of surgery, extubated and 
transferred to the post-anesthesia care unit. The incidence and severity 
of sore throat were assessed at 1, 6 and 24 hours post-extubation. 
Severity of sore throat were graded on a 4 point scale, p <0.05 was 
considered significant. 
 
Results: Incidence of POST in Dexamethasone group was found 
significantly low compared to the control group up to six hours (p<0.05) 
but was comparable at 24 hours post extubation. Severity of POST in the 
study group was of lower grade in compare to control group. 
 
Conclusions: Prophylactic intravenous Dexamethasone 8 mg 
administered to patients undergoing elective surgeries requiring 
endotracheal tube intubation significantly reduces the incidence and 
severity of POST up to six hours post-extubation. 
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INTRODUCTIONS 
 
Postoperative sore throat (POST) is a common 
adverse event after general anesthesia with 
endotracheal tube intubation. It has a 
reported incidence in various studies ranging 
from 21 to 65%.1-9It eventually leads to 
unpleasant memories and dissatisfaction in 
patients.2 mediated by an aseptic 
inflammatory process due to localized trauma 
to the pharyngeal, laryngeal and tracheal 
mucosa during the process of airway 
instrumentation leads to POST.4  
 
Endotracheal tube (ETT) cuff designs,6,8 
smaller sized tubes,7 topical lidocaine,9 steroid 
coated ETT,10 inhalation of steroid,11 gargling 
with sodium azulene sulphate,12 ketamine 
gargle13,14 steroid gels15 and steroid 
injections16-19 such as dexamethasone, a 
potent corticosteroid with anti-inflammatory 
property have been studied to prevent POST.  
 
We conducted this study to determine the 
efficacy of prophylactic intravenous 8.0 mg of 
dexamethasone in attenuating POST in 
Nepalese population. 
 
 
METHODS 
 
This prospective, double blind, randomized, 
placebo-controlled study was carried out at 
National Academy of Medical Sciences 
(NAMS), Nepal, over the period of six months 
from January till June 2014. Study was 
conducted on adult subjects of 18 years of 
age and older of either sex; American Society 
of Anesthesiologists (ASA) physical status I 
and II; undergoing elective surgeries requiring 
endotracheal tube (ETT) intubation lasting 60-
180 minutes.  
 
Exclusion criteria were patients with a history 
of recent respiratory tract infection, difficult 
intubation requiring more than 3 intubating 
attempts with conventional laryngoscopy, oral 
cavity surgery, patients on steroid therapy, 
any contraindication/allergy to corticosteroid 
medications and use of nasogastric tube and 
throat packs. 
 
Assuming dexamethasone reduces the 
incidence of POST to half18 and taking 
confidence interval of 95% and power of 80%, 
sample size was estimated as 50 patients in 
each group. Allowing for a dropout rate of 
10%, 55 patients in each group were taken. 
 
After pre-anesthetic check-up done by one of 
the researchers, informed written consent 
was obtained for the study. Study subjects 
were pre-medicated with oral diazepam (5 mg 
for patients weighing up to 50 kgs and 10 mg 
for patients more than 50 kgs) night before 
the surgery. 
 
The patients were randomly divided into two 
groups as A (Control group, n=55) and B 
(Dexamethasone group, n=55) by lottery 
method. Randomization was done by 
preparing 110 sealed envelopes with 55 slips 
of A or 55 slips of B. All the envelopes were 
placed in a box and on the day of surgery one 
slip was withdrawn from the box for each 
patient to assign group A or B accordingly.  
 
Anesthetic resident, not participating in 
postoperative patient evaluations, prepared 
the study drugs as a 4 ml clear solution in 
identical 5 ml syringes.  Due to unavailability 
of trained manpower in the pre-anesthetist 
checkup (PAC) room, we had to take help of 
anesthetic resident. According to the sealed 
randomization code, only accessible to the 
anesthetic resident, patients received either 
an injection of Dexamethasone (Group B) 8 
mg I.V. or an equivalent volume of Normal 
Saline (Group A) in PAC room just before 
entering to operation theatre. The resident 
was asked to maintain confidentiality and 
record in a note book the administered drug 
to the patient according to the sealed 
randomization code in case de-blinding was 
necessary. The randomized process and the 
identity of the study drugs were blinded from 
the patients, the primary researcher 
anesthesiologist, and the investigator who 
collected the postoperative data till the data 
analysis was started. 
 
In the operation theatre, standard monitors 
including pulse oximeter, noninvasive blood 
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pressure, 3 lead Electrocardiogram were 
applied and baseline parameters recorded.  
 
All the patients received a similar anesthesia 
involving premedication with midazolam 
0.05mg/kg and Fentanyl 2 mcg/kg just before 
induction with Propofol 2 mg/kg. Orotracheal 
intubation was facilitated by Vecuronium 
Bromide 0.12 mg/kg with a single lumen high 
volume, low pressure ETT. Male patients 
received 7.5 mm internal diameter (ID) ETT 
and female patients received a 7 mm ID ETT. 
Laryngoscopy and intubation were performed 
by using standard 3 or 4 Macintosh 
laryngoscope blades. The intubation difficulty 
felt intubating anesthetist was recorded. 
 
The cuff was inflated just to the point of 
obtaining a seal in the presence of positive 
airway pressure and maintaining intracuff 
pressure of <30 cm H 2 O every 30 minutes by 
using a handheld cuff inflator with pressure 
gauge. Intraoperatively, anesthesia was 
maintained with O 2 , Isoflurane, Fentanyl and 
Vecuronium. At the end of surgery, residual 
neuromuscular blockade was reversed with 
mixture of Neostigmine 0.05 mg/kg and 
Glycopyrrolate 0.01 mg/kg. After 
oropharyngeal suctioning under direct vision, 
extubation was done when patients could 
maintain their airway and obey verbal 
command. Any episode of coughing or 
straining on the tube during extubation were 
recorded and patient transferred to post-
anesthesia care unit, where incidence and 
severity of sore throat were assessed at 1, 6 
and 24 hours postoperatively. Severity of 
post-extubation sore throat was graded on 4 
point scale,15 as given in the table 1. 
 
Postoperative analgesia was provided with 
15mg/Kg body wt. of intravenous 
paracetamol 6 hourly and intramuscular 
pethidine 1 mg/kg as needed and the number 
of analgesic doses given was recorded. All 
patients were followed up for 24 hours post-
extubation. 
 
Data were represented as numerical 
(continuous and discrete) and categorical 
(nominal and ordinal) data. Data was analyzed 
by using SPSS ver16.0. Independent sample t-
test were used for analyzing numerical data 
and Chi-square test for analyzing categorical 
data. P values <0.05 were considered 
statistically significant.  
 
 
RESULTS 
 
There were 55 patients in group A and B with 
no dropout in both groups. In our study, there 
was no significant difference in two groups, 
no sore throat was seen in 45 (81.8%) in 
group A and 47 (85.5%) group B, duration of 
ETT in situ was 78.60 and 76.05 mins in group 
A and B.  Patient characteristics including 
factors associated with postoperative sore 
throat were comparable in both groups, 
(Table 2). 
 
The incidence of POST was less in the 
Dexamethasone Group than Control. The 
decrease was statistically significant only up 
to the first 6 hours (Table 3). Regarding the 
severity of POST, a significant number of 
patients in the Dexamethasone Group had no 
 
sore throat at all up to 6 hours post 
extubation.  Even those who had POST in that 
group were of less severity than the Control 
Group (Table 4). None of the patients had 
severe sore throat during study time in the 
Dexamethasone Group.  
 
Table 1. Scoring system for assessment of severity of sore throat 
 
 
Score Grading Description 
0 No sore throat  No complaint at any time since the operation 
1 Minimal sore throat Patient answers in the affirmative when asked about sore throat 
2 Moderate sore throat Patient complains of sore throat on his/her own 
3 Severe sore throat Patient is in obvious distress 
Table 2. Patient characteristics including factors associated with postoperative sore throat 
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Variables  Group A (n=55) Group B (n=55) p value 
Age in years (mean±SD) 42.78±10.83 46.04±7.58 0.07 
Sex  Male  33 (60%) 27 (49.1%) 0.251 
Female  22 (40%) 28 (50.9%) 
ASA I 33 (60%) 35 (63.6%) 0.695 
II 22 (40%) 20 (36.4%) 
Weight in Kg (mean±SD) 56.45±8.36 55.15±9.76 0.452 
postoperative pethidine doses required 
in 24 hours 
1 dose 0 0 0.845 
2 doses 34 (61.8%) 33 (60%) 
3 doses 21 (31.8%) 22 (40%) 
Size of ETT 7.5 mm ID 33 (60%) 27 (49.1%) 0.251 
7.0mm ID 22 (40%) 28 (50.9%) 
No. of attempts of intubation 1 51 (92.7%) 51 (92.7%) 0.264 
2 2 (3.6%) 4 (7.3%) 
3 2 (3.6%) 0 
Intubation difficulty encountered No  51 (92.7%) 51 (92.7%) 1.0 
Yes  4 (7.3%) 4 (7.3%) 
Duration of ETT in situ in mins (mean±SD) 78.60±9.11 76.05±9.36 0.151 
Coughing or straining during 
extubation 
No  45 (81.8%) 47 (85.5%) 0.606 
Yes  10 (18.2%) 8 (14.5%) 
 
Table 3. Incidence of post-operative sore throat at 1, 6 and 24 hours post-extubation 
 
 
Incidence of POST at Group A (n=55) Group B (n=55) p value 
 1 hr 28 (50.9%) 16 (29.1%) 0.020* 
 6 hrs 32 (58.2%) 17 ( 30.9%) 0.004* 
 24 hrs 27 (49.1%) 18 (32.7%) 0.081 
 
Table 4. Severity grading of post-operative sore throat at different time intervals 
 
 
Severity Grading of POST Group A (n=55) Group B (n=55) p Value 
 
at 1 hr 
No sore throat 27 (49.1%) 39 (70.9%) 0.020* 
Minimal sore throat 16 (29.1%) 7 (12.7%) 0.035* 
Moderate sore throat 9 (16.4%) 9 (16.4%) 1.000 
Severe sore throat 3 (5.5%) 0 0.079 
 
at 6 hrs 
No sore throat 23 (41.8%) 38 (69.1%) 0.004* 
Minimal sore throat 26 (47.3%) 15 (27.3%) 0.030* 
Moderate sore throat 6 (10.9%) 2 (3.6%) 0.142 
Severe sore throat 0 0  
 
at 24 hrs 
No sore throat 28 (50.9%) 37 (67.3%) 0.081 
Minimal sore throat 26 (47.3%) 18 (32.7%) 0.119 
Moderate sore throat 1 (1.8%) 0 0.315 
Severe sore throat 0 0  
 
DISCUSSIONS 
 
In the present study, the incidence of POST in 
control group without Dexamethasone were 
50.9%, 58.2% and 49.1%  at 1, 6 and 24 hours 
post extubation respectively, similar to other 
studies.16-19 This is quite high leading to 
patient distress and dissatisfaction. 
This study demonstrated that prophylactic 
intravenous dexamethasone 8 mg is effective 
in reducing the incidence of POST significantly 
till 6 hours post extubation (29.1% in 1 hour 
and 30.9%in 6 hours) but had no difference at 
24 hours postoperatively with the control 
group. Severity scores were also of less grade 
in the Dexamethasone group at all study 
periods. 
 
Different researchers have compared the 
effect of various doses of dexamethasone on 
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POST with the control groups. Similar to our 
study, Bagchi D, et al.19 showed a significant 
reduction (approximately 30%) in the 
incidence of POST with prophylactic 0.2mg/kg 
of dexamethasone (48.9%) compared to 
placebo (18.8%) in the first hour of 
extubation. Similarly, Park et al.16found a 
significant decrease in incidence of POST at 
1hour post-extubation by 22% and 42% with 
prophylactic IV dexamethasone 0.1 mg/kg and 
0.2 mg/kg respectively when compared to 
placebo and a 30% decrease at 24 hours post-
extubation with IV dexamethasone 0.2 mg/kg. 
Thomas S, et al.18 reported a 36.3% decrease 
in incidence of sore throat at 24 hours post-
extubation with IV dexamethasone 8mg 
preoperatively. However, in contrast to our 
study, Park, et al.17 found a nonsignificant 
difference in POST incidence but the severity 
was significantly less in patients receiving 
prophylactic dexamethasone (10 mg) 30 
minutes before intubation in comparison to 
post intubation dexamethasone. Various rate 
of incidence of POST among the above 
mentioned studies might be due to the use of 
different doses of dexamethasone (0.2 mg/kg 
to 10.0 mg) and anesthetic techniques used 
such as use of double lumen tubes, constant 
monitoring and maintaining of ETT cuff 
pressure less than 30 cm of H 2 O, 
administration of dexamethasone pre or post 
intubation. We standardized the contributing 
factors of POST,4 including ETT cuff design, 
intra-cuff pressure, type of operation, 
coughing or bucking on the ETT and duration 
of tracheal intubation. The type and dose of 
analgesics used during the study period were 
comparable between the study groups. 
 
The mechanism of reduction of POST with 
systemic prophylactic steroid is probably 
based on its anti-inflammatory activity which 
includes inhibition of leukocyte migration to 
the inflammation site and stabilization of cell 
membrane integrity.20,21 
 
Single dose of systemic dexamethasone has 
the added benefit of prophylaxis from post-
operative nausea vomiting22 but its 
administration might be associated with 
adverse events, such as glucose intolerance, 
susceptibility to infections, delayed wound 
healing and adrenal suppression. 
 
Sore throat is a very subjective entity resulting 
in a high chance of biased assessment which 
could be one of our limitations. Various 
factors such as ethnic groups, enrolled 
subjects level of education must be 
considered before objectively generalizing the 
incidence of POST. 
 
 
CONCLUSIONS 
 
Prophylactic administration of intravenous 
dexamethasone 8.0 mg can significantly 
reduce the incidence of POST following 24 
hours of tracheal extubation. Subsequently, 
the severity of POST can also be reduced till 
six hours following extubation. 
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